Active Biotech AB (publ)

OM:ACTI Stock Report

Market Cap: SEK 149.1m

Active Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACTI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders367,0301.39%
Institutions1,921,5167.29%
Private Companies5,520,25020.9%
General Public18,551,87570.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 114.3%.

Top Shareholders

Top 18 shareholders own 30.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13%
MGA Holding AB
3,421,850SEK 19.4m78.1%no data
7.33%
Sjuenda Holding AB
1,933,400SEK 10.9m0%no data
2.74%
Avanza Fonder AB
721,195SEK 4.1m0%no data
2.01%
Handelsbanken Asset Management
528,929SEK 3.0m0%no data
1.7%
Fourth Swedish National Pension Fund (AP4)
448,100SEK 2.5m0%no data
1.37%
Tredje AP-fonden
361,350SEK 2.0m0%no data
0.78%
Michael Shalmi
206,013SEK 1.2m0%no data
0.63%
StÄVie FÖRvaltnings Ab
165,000SEK 933.1k0%no data
0.56%
SEB Foundation
147,733SEK 835.4k0%0.12%
0.47%
Ann-Louise Olander
124,061SEK 701.6k0%no data
0.11%
Nordnet Pensionsförsäkring AB
27,779SEK 157.1k0%no data
0.046%
Helen Tuvesson
12,068SEK 68.2k0%no data
0.033%
Hans Kolam
8,621SEK 48.7k0%no data
0.022%
Aleksandar Danilovski
5,715SEK 32.3k0%no data
0.02%
Axel Glasmacher
5,400SEK 30.5k0%no data
0.017%
Erik Vahtola
4,522SEK 25.6k0%no data
0.0024%
Uli Hacksell
630SEK 3.6k0%no data
0.00046%
Nordnet AB (publ)
122SEK 685.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/05 01:31
End of Day Share Price 2026/07/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Active Biotech AB (publ) is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan WaldenlindCarnegie Investment Bank AB
Thomas BowersDanske Bank
Robin DavisonEdison Investment Research